KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Equity Average (2016 - 2025)

Historic Equity Average for Precigen (PGEN) over the last 13 years, with Q3 2025 value amounting to $2.5 million.

  • Precigen's Equity Average fell 9483.59% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 9483.59%. This contributed to the annual value of $78.5 million for FY2024, which is 3585.03% down from last year.
  • According to the latest figures from Q3 2025, Precigen's Equity Average is $2.5 million, which was down 9483.59% from -$25.4 million recorded in Q2 2025.
  • Precigen's Equity Average's 5-year high stood at $175.2 million during Q2 2023, with a 5-year trough of -$25.4 million in Q2 2025.
  • Its 5-year average for Equity Average is $96.1 million, with a median of $107.8 million in 2024.
  • Its Equity Average has fluctuated over the past 5 years, first skyrocketed by 17055.81% in 2023, then crashed by 13626.46% in 2025.
  • Quarter analysis of 5 years shows Precigen's Equity Average stood at $119.3 million in 2021, then increased by 12.66% to $134.4 million in 2022, then dropped by 0.97% to $133.1 million in 2023, then plummeted by 64.73% to $46.9 million in 2024, then tumbled by 94.58% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, -$25.4 million for Q2 2025, and $12.2 million during Q1 2025.